Stereoselective reversible ketone formation from 10-hydroxylated nortriptyline metabolites in human liver

References

• Ahmed N. K., Felsted R. L., Bachur N. R. Heterogeneity of anthracycline antibiotic carbonyl reductases in mammalian liver. Biochemical Pharmacology 1978; 27: 2713–2719
   PubMed Web of Science ®Google Scholar
• Baier-Weber B., Prox A., Wachsmuth H., Breyer-Pfaff U. Glucuronides of hydroxylated metabolites of amitriptyline and nortriptyline isolated from rat bile. Drug Metabolism and Disposition 1988; 16: 490–496
   PubMed Web of Science ®Google Scholar
• Bertilsson L., Alexanderson B. Stereospecific hydroxylation of nortriptyline in man in relation to interindividual differences in its steady-state plasma level. European Journal of Clinical Pharmacology 1972; 4: 201–205
   Web of Science ®Google Scholar
• Bickl M. H. Metabolism of antidepressants. Psychtropic Agents, Handbook of Experimental Pharmacology, F. Hoffmeister, G. Stille. Springer, Berlin 1980; vol. 55/1: 551–572
   Google Scholar
• Bock J. L., Giller, Gray E. S., Jatlow P. Steady-state plasma concentrations of cis-and trans-10-OH amitriptyline metabolites. Clinical Pharmacology and Therapeutics 1982; 31: 609–616
   PubMed Web of Science ®Google Scholar
• Bohren K. M., Wermuth B., Harrison D., Ringe D., Petsko G. A., Gabbay K. H. Expression, crystallization and preliminary crystallographic analysis of human carbonyl reductase. Journal of Molecular Biology 1994; 244: 659–664
   PubMed Web of Science ®Google Scholar
• Breyer-Pfaff U., Becher B., Nusser E., Nill K., Baier-Weber B., Zaunbrecher D., Wachsmuth H., Prox A. Quaternary N-glucuronides of 10-hydroxylated amitriptyline metabolites in human urine. Xenobiotica 1990; 20: 727–738
   PubMed Web of Science ®Google Scholar
• Breyer-Pfaff U., Pfandl B., Nill K., Nusser E., Monney C., Jonzier-Perey M., Baettig D., Baumann P. Enantioselective amitriptyline metabolism in patients phenotyped for two cytochrome P450 isozymes. Clinical Pharmacology and Therapeutics 1992; 52: 350–358
   PubMed Web of Science ®Google Scholar
• Breyer-Pfaff U., Prox A., Wachsmuth H., Yao P. Phenolic metabolites of amitriptyline and nortriptyline in rat bile. Drug Metabolism and Disposition 1987; 15: 882–889
   PubMed Web of Science ®Google Scholar
• Dahl M. L., Nordin C., Bertilsson L. Enantioselective hydroxylation of nortriptyline in human liver microsomes, intestinal homogenate, and patients treated with nortriptyline. Therapeutic Drug Monitoring 1991; 13: 189–194
   PubMed Web of Science ®Google Scholar
• Dahl-Puustinen M. L., Dumont E., Bertilsson L. Glucuronidation of E-10-hydroxynortriptyline in human liver, kidney, and intestine. Organ-specific differences in enantioselectivity. Drug Metabolism and Disposition 1989a; 17: 433–435
   PubMed Web of Science ®Google Scholar
• Dahl-Puustinen M. L., Perry T. L., Jr, Dumont E., Von Bahr C., Nordin C., Bertilsson L. Stereoselective disposition of racemic E-10-hydroxynortriptyline in human beings. Clinical Pharmacology and Therapeutics 1989b; 45: 650–656
   PubMed Web of Science ®Google Scholar
• Deyashiki Y., Ogasawara A., Nakayama T., Nakanishi M., Miyabe Y., Sato K., Hara A. Molecular cloning of two human liver 3α-hydroxysteroid/dihydrodiol dehydrogenase isoenzymes that are identical with chlordecone reductase and bile-acid binder. Biochemical Journal 1994; 299: 545–552
   PubMed Web of Science ®Google Scholar
• Deyashiki Y., Taniguchi H., Amano T., Nakayama T., Hara A., Sawada H. Structural and functional comparison of two human liver dihydrodiol dehydrogenases associated with 3α-hydroxysteroid dehydrogenase activity. Biochemical Journal 1992; 282: 741–746
   PubMed Web of Science ®Google Scholar
• Eyles D. W., Pond S. M. Stereospecific reduction of haloperidol in human tissues. Biochemical Pharmacology 1992; 44: 867–871
   PubMed Web of Science ®Google Scholar
• Flynn T. G., Green N. C. The aldo-keto reductases: an overview. Enzymology and Molecular Biology of Carbonyl Metabolism 4, H. Weiner, D. W. Crabb, T. G. Flynn. Plenum, New York 1993; 251–257
   Google Scholar
• Kudo K., Amuro Y., Hada T., Higashino K. Purification and properties of 3α-hydroxysteroid dehydrogenase as a 3-keto bile acid reductase from human liver cytosol. Biochimica et Biophysica Acta 1990; 1046: 12–18
   PubMedGoogle Scholar
• Litters N., Schmelzeisen-Redeker G. Erfahrungen mit der schnellen HPLC im analytischen Routinelabor. GIT Fachzeitschrift für das Labor 1989; 1989: 81–83
   Google Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Maser E. Xenobiotic carbonyl reduction and physiological steroid oxidoreduction. The pluripotency of several hydroxysteroid dehydrogenases. Biochemical Pharmacology 1995; 49: 421–440
   PubMed Web of Science ®Google Scholar
• Maser E., Gebel T., Netter K. J. Carbonyl reduction of metyrapone in human liver. Biochemical Pharmacology 1991; 42: S93–S98
   PubMed Web of Science ®Google Scholar
• Mellström B., Bertilsson L., Sawe J., Schulz H. U., Sjöqvist F. E- and Z-10-hydroxylation of nortriptyline: Relationship to polymorphic debrisoquine hydroxylation. Clinical Pharmacology and Therapeutics 1981; 30: 189–193
   PubMed Web of Science ®Google Scholar
• Molowa D. T., Shayne A. G., Guzelian P. S. Purification and characterization of chlordecone reductase from human liver. Journal of Biological Chemistry 1986; 261: 12624–12627
   PubMed Web of Science ®Google Scholar
• Nusser E., Nill K., Breyer-Pfaff U. Enantioselective formation and disposition of (E)- and (Z)-10-hydroxynortriptyline. Drug Metabolism and Disposition 1988; 16: 509–511
   PubMed Web of Science ®Google Scholar
• Ohara H., Nakayama T., Deyashiki Y., Hara A., Miyabe Y., Tsukada F. Reduction of prostaglandin D2 to 9α, 11β-prostaglandin F2 by a human liver 3α-hydroxysteroid/dihydrodiol dehydrogenase isozyme. Biochimica et Biophysica Acta 1994; 1215: 59–65
   PubMedGoogle Scholar
• Pfandl B., Mörike K., Winne D., Schareck W., Breyer-Pfaff U. Stereoselective inhibition of nortriptyline hydroxylation in man by quinidine. Xenobiotica 1992; 22: 721–730
   PubMed Web of Science ®Google Scholar
• Prox A., Breyer-Pfaff U. Amitriptyline metabolites in human urine: identification of phenols, dihydrodiols, glycols, and ketones. Drug Metabolism and Disposition 1987; 15: 890–896
   PubMed Web of Science ®Google Scholar
• Schieber A., Frank R. W., Ghisla S. Purification and properties of prostaglandin 9-ketoreductase from pig and human kidney. Identity with human carbonyl reductase. European Journal of Biochemistry 1992; 206: 491–502
   PubMedGoogle Scholar
• Stolz A., Hammond L., Lou H., Takikawa H., Ronk M., Shively J. E. cDNA cloning and expression of the human hepatic bile acid-binding protein. A member of the monomeric reductase gene family. Journal of Biological Chemistry 1993; 268: 10448–10457
   PubMed Web of Science ®Google Scholar
• Takikawa H., Stolz A., Sugiyama Y., Yoshida H., Yamanaka M., Kaplowitz N. Relationship between the newly identified bile acid binder and bile acid oxidoreductases in human liver. Journal of Biological Chemistry 1990; 265: 2132–2136
   PubMed Web of Science ®Google Scholar
• Veech R. L., Eggleston L. V., Krebs H. A. The redox state of free nicotinamide-adenine dinucleotide phosphate in the cytoplasm of rat liver. Biochemical Journal 1969; 115: 609–619
   PubMed Web of Science ®Google Scholar
• Wermuth B. Purification and properties of an NADPH-dependent carbonyl reductase from human brain. Relationship to prostaglandin 9-ketoreductase and xenobiotic ketone reductase. Journal of Biological Chemistry 1981; 256: 1206–1213
   PubMed Web of Science ®Google Scholar
• Wermuth B. Aldo-keto reductases. Enzymology of Carbonyl Metabolism 2, T. G. Flynn, H. Weiner. Liss, New York 1985; 209–230
   Google Scholar
• Wermuth B., Bohren K. M., Heinemann G., von Wartburg J. P., Gabbay K. H. Human carbonyl reductase. Nucleotide sequence analysis of a cDNA and amino acid sequence of the encoded protein. Journal of Biological Chemistry 1988; 263: 16185–16188
   PubMed Web of Science ®Google Scholar
• Wermuth B., Münch J. D. B., von Wartburg J. P. Stereospecificity of hydrogen transfer of aldehyde reductase. Experientia 1979; 35: 1288–1289
   PubMedGoogle Scholar
• Wermuth B., Platt K. L., Seidel A., Oesch F. Carbonyl reductase provides the enzymatic basis of quinone detoxication in man. Biochemical Pharmacology 1986; 35: 1277–1282
   PubMed Web of Science ®Google Scholar
• Westbrook C., Lin Y. M., Jarabak J. NADP-linked 15-hydroxyprostaglandin dehydrogenase from human placenta: partial purification and characterization of the enzyme and identification of an inhibitor in placental tissue. Biochemical and Biophysical Research Communications 1978; 76: 943–949
   Web of Science ®Google Scholar
• Winters C. J., Molowa D. T., Guzelian P. S. Isolation and characterization of cloned cDNAs encoding human liver chlordecone reductase. Biochemistry 1990; 29: 1080–1087
   PubMed Web of Science ®Google Scholar